Research
Lake Street Initiates Verrica Pharmaceuticals at Buy With $9 Price Target
Verrica Pharmaceuticals (VRCA) has an average rating of buy and mean price target of $13.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$VRCA
